Molecular Pharmacology and Novel Potential Therapeutic Applications of Fingolimod.
Pournajaf S, Dargahi L, Javan M, Pourgholami MH.
Pournajaf S, et al.
Front Pharmacol. 2022 Feb 16;13:807639. doi: 10.3389/fphar.2022.807639. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35250559
Free PMC article.
Review.
In addition to exerting inhibitory effects on sphingolipid pathway enzymes, fingolimod also inhibits histone deacetylases, transient receptor potential cation channel subfamily M member 7 (TRMP7), cytosolic phospholipase A2alpha (cPLA2alpha), reduces lysophosphatidic acid …
In addition to exerting inhibitory effects on sphingolipid pathway enzymes, fingolimod also inhibits histone deacetylases, transient recepto …